Core Viewpoint - 泰禾股份 is initiating its IPO with a share price of 10.27 yuan and a PE ratio of 13.4 times, focusing on the research, production, and sales of pesticide products and functional chemicals [1] Company Overview - 泰禾股份 specializes in the development, production, and sales of pesticide products and functional chemicals, holding a leading position in key products such as 百菌清, 嘧菌酯, and 2,4-D [1] - The company leverages its proprietary technology and extensive manufacturing management experience to serve global customers, establishing itself as a group manufacturing enterprise with industry-leading capabilities [1] Financial Performance - The company reported revenues of approximately 35.79 billion yuan, 50.99 billion yuan, 38.68 billion yuan, and 19.59 billion yuan for the years 2021, 2022, 2023, and the first half of 2024, respectively [2] - Net profits for the same periods were approximately 4.31 billion yuan, 6.62 billion yuan, 3.38 billion yuan, and 1.1 billion yuan [2] Asset and Liability Metrics - As of June 30, 2024, total assets amounted to 51,014.19 million yuan, with equity attributable to shareholders at 28,608.27 million yuan [3] - The company's asset-liability ratio for the parent company was 23.86% and for the consolidated entity was 35.72% [3] Strategic Partnerships - 泰禾股份 has established long-term strategic partnerships with multinational companies such as Syngenta, Dow, and Honeywell, enhancing its market presence in regions including South America, North America, Southeast Asia, and Europe [2]
A股申购 | 泰禾股份(301665.SZ)开启申购 主营百菌清、嘧菌酯等农药产品